Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Promega Introduces New Mass Spec Reagents, IdeS Protease and Human and Yeast Protein Extracts
Thursday, June 26, 2014
New reagents enable optimal digestion, method development and instrument monitoring for LC/MS

New XFp Analyzer from Seahorse Bioscience
Wednesday, June 25, 2014
Makes measuring metabolism affordable for every lab.

Summer 2014 Program of Lyophilization Webinars
Tuesday, June 24, 2014
LyoLearn program devoted to lyophilization, freeze-drying and related topics.

Agilent Introduces Novel Synthetic Biology System
Saturday, June 21, 2014
QuikChange HT system accelerates protein engineering.

Diamond Light Source Purchases Multiple Electron Microscopes from FEI
Thursday, June 19, 2014
The U.K.’s national synchrotron now has a complete cryo-EM workflow for integrative structural biology to explore essential biological questions at the atomic and molecular scale.

Protea Announces HRAM Analytical Services
Tuesday, June 17, 2014
Adds HRAM to its mass spectrometry based molecular imaging and LC-MS bioanalytical services portfolio.

Protea Announces Ion Mobility Mass Spec Imaging Services
Tuesday, June 17, 2014
Ion mobility for metabolite and lipid profiling is added to its mass spectrometry-based molecular imaging services portfolio.

New 1mL ISOLUTE® SLE+ 48-well Plates from Biotage
Tuesday, June 17, 2014
Enabling the extraction of larger sample volumes, faster! Med chem, proteomics, bioprocessing and screening

Owlstone Introduces UltraFAIMS for Improved Mass Spectrometry
Monday, June 16, 2014
A low-cost accessory for mass spectrometers that provides an additional dimension of high-speed separation by ion mobility.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 1224
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv